利菲特格拉斯特的安全性:基于FAERS的现实世界药监测研究
Chu Zhang1, Hui Wang2, Xianglei Chen1
1Chizhou Aier Eye Hospital, Chizhou, Anhui, China.
PloS one
|April 24, 2025
概括
这项研究分析了FDA不良事件报告系统对Lifitegrast的数据,确定了230个眼睛安全信号. 一些事件,如青光眼和白内障,没有在药物中.
科学领域:
- 眼科医生 眼科 眼科
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
背景情况:
- 利菲特格拉斯特是一种用于治疗干眼疾病的药物.
- 全面的安全评估对于有效的药物使用至关重要.
研究的目的:
- 使用FDA不良事件报告系统 (FAERS) 数据进行Lifitegrast的全面安全评估.
- 识别潜在的安全信号,并与现有的药物标签进行比较.
主要方法:
- 追溯分析FAERS数据从2016年第三季度到2024年第二季度.
- 不成比例分析以检测与 Lifitegrast 相关的安全信号.
- 与Lifitegrast产品插入信息进行识别的不良事件的比较.
主要成果:
- 在超过1300万份AE报告中,有12,393份报告将Lifitegrast列为首要可疑药物.
- 确定了230个眼部不良事件 (AE) 信号,其中104个被多个算法检测到.
- 71个副作用与产品标签一致 (例如,眼部刺激,疼痛,胀),而其他副作用,如青光眼和白内障,则不同.
- 副作用在男性和65岁以上的人群中更为频繁.
结论:
- 分析发现了Lifitegrast的已知和以前未报告的眼部安全信号.
- 这些发现强调了持续药物监测对于干眼疾病治疗的重要性.
- 这些数据可以为临床实践提供信息,以优化Lifitegrast的使用和患者安全.
更多相关视频
10:33An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use
Published on: May 24, 2024
594
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
8.2K
相关概念视频
Pharmacovigilance
739
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
739
Drug Regulation
1.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.2K
Clinical Trials: Overview
2.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.4K
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Factors Affecting Drug Response: Overview
1.7K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.7K
Renal Failure: Dose Adjustments
35
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
35
